Gohealth Inc GOCO.OQ GOCO.O is expected to show a fall in quarterly revenue when it reports results on February 25 (estimated) for the period ending December 31 2025
The Chicago Illinois-based company is expected to report a 76.9% decrease in revenue to $89.91 million from $389.13 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.
LSEG's mean analyst estimate for Gohealth Inc is for a loss of $1.12 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Gohealth Inc is $10.00, about 517.3% above its last closing price of $1.62
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2025 | -1.87 | -2.02 | -11.80 | Missed | -483.6 |
Jun. 30 2025 | -2.71 | -2.58 | -0.12 | Beat | 95.4 |
Mar. 31 2025 | -0.25 | -0.29 | -0.52 | Missed | -76.9 |
Dec. 31 2024 | 1.30 | 1.16 | 2.19 | Beat | 88.3 |
Sep. 30 2024 | -3.29 | -3.19 | 0.46 | Beat | 114.4 |
Jun. 30 2024 | -2.36 | -2.47 | -2.70 | Missed | -9.2 |
Mar. 31 2024 | -0.96 | -0.95 | -1.04 | Missed | -9.1 |
Dec. 31 2023 | 2.74 | 2.73 | -0.22 | Missed | -108.1 |
This summary was machine generated February 23 at 13:45 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)